- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 935
Trace Genomics to grow with $13m
The soil analytics provider took its total funding to $19m in a round featuring agricultural investment, data and media platform AgFunder.
Nov 15, 2018Ucommune absorbs $200m of series D cash
Ucommune, a China-based workspace provider backed by corporates including Prosperity Holdings, Junfa Group and Dahong Group, has now raised $715m altogether.
Nov 15, 2018LeanTaas gets more Insight in $15m round
LeanTaas, which counts Sedgwick Claims Management Services as an investor, closed a series C round led by Insight Venture Partners that will fund the growth of its platform.
Nov 15, 2018University Ventures enrols in Unicaf’s latest round
Online higher education platform Unicaf has raised series B funding from a consortium also including Goldman Sachs, EdX and CDC Group as it gears up to target more students.
Nov 15, 2018Crossword looks to Aim for clues
The cybersecurity commercialisation firm hopes to raise $2.9m through an Aim placement and will use the funding for product development, working capital, sales and marketing.
Nov 15, 2018Kebotix collects $5m
Kebotix has emerged from Harvard University with backing from investors including Baidu to commercialise an automated approach to discovering new materials and molecules.
Nov 15, 2018UiPath reaches $265m series C close
Enterprise automation software provider UiPath has added $40m to a round co-led by existing investor CapitalG that values it at $3bn.
Nov 15, 2018Nikola inflates series C round to $210m
Nikola Corporation has doubled the size of a Nel-backed round to $210m, valuing it at $1.3bn post-money as it gears up to launch its hydrogen-powered semi-truck.
Nov 15, 2018NextCure looks forward with $93m
Strategic partner Eli Lilly invested $15m while Pfizer, Ping An Ventures and Taiho Ventures also contributed to the immunotherapy developer's series B round.
Nov 15, 2018Kymera reels in $65m
Pfizer Ventures and 6 Dimensions Capital joined Merck & Co, Sanofi, Eli Lilly and Amgen in Kymera's series B round, taking the protein degradation drug developer's total funding to more than $95m.
Nov 15, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


